healthcare
Artificial intelligence firm Osmo is working diligently to bring back the future we were promised in 1960 when Hans Laube introduced the world to “Smell-O-Vision.” Only this time, the goal is to improve the lives of humans everywhere by teaching computers how to interpret scent. Osmo’s technology is a complex, multidisciplinary amalgamation of science and engineering at the cutting edge, but its purpose is simple. The company wants to build generative AI that can do for scents what OpenAI’s ChatGPT and Google’s Gemini can do for sounds and images. Per the company’s website: “In this new era, c...
Cointelegraph
In the last decade, Ben has taken part in 15 paid clinical trials. The 37-year-old from Cambridge in the UK became a human guinea pig for the reason most people do: money. “I’d had my first child, and the childcare bill was more than I was earning per month. So I did trials using my annual leave entitlement to earn some extra cash,” Ben told Euronews Health. The very first trial he participated in was for an anti-inflammatory drug and run by Quotient Sciences, a UK-based drug development company. “(Quotient Sciences) were a really great team who explained the trial and risks to me fully. I had...
Euronews (English)
Concussion patients can develop persistent, sometimes severe symptoms as a result of their head injury, but traditional tests often fail to identify which patients are most at-risk. Now, a group of international researchers has found a way to improve the odds. Typically, doctors observe patients when they come to the hospital with a possible brain injury, and they may order a CT scan to check for bruising, bleeding, or swelling. But the new study, published in the Lancet-affiliated eClinicalMedicine00330-4/fulltext), found that another type of brain scan, known as diffusion tensor imaging MRI ...
Euronews (English)
Female patients are less likely to be prescribed pain medication compared to male patients under similar conditions in emergency departments, a new study has found. Researchers from the US and Israel analysed over 21,000 patient records in the two countries. They noted that women are prescribed fewer pain relief medications for both opioids and non-opioids than male patients. Their findings were published in the journal Proceedings of the National Academy of Sciences(PNAS). This discrepancy spans across medical professionals, with both male and female physicians prescribing fewer pain-relief m...
Euronews (English)
A seven-year-old in the UK has become the first child in the country to get kidney surgery with a pioneering robot-assisted device. Reece had an obstruction that inhibited the flow of urine from his kidney. "He went to the park, and he fell on some sort of pole. He said he was okay, then went to my dad’s in the evening, and played some games, he went to the toilet and there was some blood in his urine,” said Reece’s mother, Elizabeth Wilton. “(At the hospital), he had scans, nothing came of that particular accident but then when he had the scans, they found out he had a problem between the kid...
Euronews (English)
There are many superlatives you could use to describe Vienna; beautiful, historic, picturesque, cultured. Now, you can add another to the list: consistent. For the third consecutive year, the Austrian capital has been crowned the most liveable city in the world out of the 173 listed in The Economist’s annual Global Liveability Index. The city’s grip on the top spot seems unassailable, with 2024 marking the ninth occasion out of the last 11 index reports it has taken the top spot. Vienna named world’s most liveable city again in 2023. Other European cities slipped out of top 10With perfect scor...
Euronews (English)
If Kevin Piette ever had any dreams of making it to the Olympics, they likely ended when the young tennis player was paralyzed in a motorcycle accident more than a decade ago. This week, however, Piette walked through the streets of Paris while carrying the Olympic flame—thanks to a genuinely awesome robotic exoskeleton. The video pretty much tells the whole story, so please enjoy: According to the Olympics' official website, the 36-year-old Piette is one of the first test "pilots" for these exoskeleton suits, which are currently being used for rehab but might soon be available for personal us...
Reason
A jab given twice-yearly to treat AIDs was found to be 100 per cent effective in preventing new infections in women, according to the results of a new study published on Wednesday. Researchers reported that there were no infections in the young women and girls who got the shots in a study of about 5,000 in South Africa and Uganda. In a group given daily prevention pills, roughly 2 per cent ended up catching HIV from infected sex partners. Nearly 40 million people living with HIV with one AIDs death a minute in 2023, new UN report says"To see this level of protection is stunning," said Salim Ab...
Euronews (English)
Political Guidelines 2024-2029 published before Von der Leyen’s reappointment as president of the EU executive last week included suggested a new action plan on cybersecurity of hospitals and healthcare providers will be presented in the first 100 days of the new mandate. The Guidelines were published a day before a massive IT outagebrought hospitals and other businesses to a halt worldwide, highlighting the reliance of health institutions on digital infrastructure. With the rapid development of digital health alongside rising awareness of data privacy and security, the EU is keen to bolster i...
Euronews (English)
For the hundreds of millions of people living with diabetes, a new study breakthrough could hold the hope for a cure. Scientists at Mount Sinai and City of Hope medical centres in the US have developed a drug treatment which was able to increase insulin-producing cells - known as beta cells - by 700 per cent over three months in mice, effectively reversing the disease. “This study is the first time a treatment, a combination treatment, has shown to increase human insulin-producing cells in vivo,” Dr Adolfo Garcia-Ocaña, corresponding author of the study, told Euronews Health. “This research br...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら